日本語 
Recruitment for this clinical study is now complete, and we are no longer accepting new participants. Thank you for your interest
Recruitment for this clinical study is now complete, and we are no longer accepting new participants. Thank you for your interest
Askanase A, Berkani O, Cahuzac c, Cornelisse p, D’Cruz D, Kalunian K, Merrill J, Pozzobon M, Navarra S. Efficacy and Safety of Cenerimod in Patients with Moderate to Severe Systemic Lupus Erythematosus (SLE): A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2b Trial [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9): 3293–3297.